Amgen Inc. Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31)
Amgen Inc. (AMGN) reported Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) of $149.00 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-04.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments · last filed 2011-11-04
- Amgen Inc. increase (decrease) in fair value of interest rate fair value hedging instruments (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $149.00M, a 96.05% increase year-over-year.
- Amgen Inc. increase (decrease) in fair value of interest rate fair value hedging instruments (deprecated 2012-01-31) for the quarter ending 2011-06-30 was -$84.00M.
- Amgen Inc. increase (decrease) in fair value of interest rate fair value hedging instruments (deprecated 2012-01-31) for the quarter ending 2011-03-31 was $47.00M.
- Amgen Inc. increase (decrease) in fair value of interest rate fair value hedging instruments (deprecated 2012-01-31) for the quarter ending 2010-09-30 was $76.00M, a 245.45% increase year-over-year.
- Amgen Inc. increase (decrease) in fair value of interest rate fair value hedging instruments (deprecated 2012-01-31) for fiscal 2010 was -$105.00M, a 190.52% decline from fiscal 2009.
- Amgen Inc. increase (decrease) in fair value of interest rate fair value hedging instruments (deprecated 2012-01-31) for fiscal 2009 was $116.00M.
| Period end | Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) 3 month | Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) 3 month as first filed | Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) 6 month | Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) 6 month as first filed | Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) 9 month | Increase (Decrease) in Fair Value of Interest Rate Fair Value Hedging Instruments (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2011-09-30 | $149.00M 10-Q · filed 2011-11-04 | $186.00M 10-Q · filed 2011-11-04 | ||||
| 2011-06-30 | -$84.00M 10-Q · filed 2011-08-08 | -$37.00M 10-Q · filed 2011-08-08 | ||||
| 2011-03-31 | $47.00M 10-Q · filed 2011-05-10 | |||||
| 2010-12-31 | -$105.00M 10-K · filed 2011-02-25 | |||||
| 2010-09-30 | $76.00M 10-Q · filed 2011-11-04 | $200.00M 10-Q · filed 2011-11-04 | ||||
| 2010-06-30 | -$107.00M 10-Q · filed 2011-08-08 | $107.00M 10-Q · filed 2010-08-09 | -$124.00M 10-Q · filed 2011-08-08 | $124.00M 10-Q · filed 2010-08-09 | ||
| 2010-03-31 | -$17.00M 10-Q · filed 2011-05-10 | |||||
| 2009-12-31 | $116.00M 10-K · filed 2011-02-25 | |||||
| 2009-09-30 | $22.00M 10-Q · filed 2010-11-08 | -$81.00M 10-Q · filed 2010-11-08 | ||||
| 2009-06-30 | -$41.00M 10-Q · filed 2010-08-09 | -$103.00M 10-Q · filed 2010-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |